The evolution of Medtech in emerging markets

US medtech companies have been the largest supplier of medtech to emerging countries such as China, India and Brazil for the past decade. This could be set to change as emerging markets present a sizable opportunity for many MedTech companies. However their dynamic nature challenges companies to maintain a pulse on evolving market conditions while planning for the long term.

We looked at how China’s domestic companies are growing rapidly to challenge medtech multinational (MNC) market shares in many mid- and high-end device segments. We also researched Latin America’s infrastructure gap is narrowing and opening up opportunities in the market that challenge US domination of the market.

View the turtl deck to find out more.